Abeona Therapeutics
ABEO
#7999
Rank
$0.39 B
Marketcap
$6.90
Share price
1.47%
Change (1 day)
7.98%
Change (1 year)

Revenue for Abeona Therapeutics (ABEO)

Revenue in 2026 (TTM): $14.54 Million USD

According to Abeona Therapeutics 's latest financial reports the company's current revenue (TTM ) is $14.54 Million USD. In 2025 the company made a revenue of $5.82 Million USD an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abeona Therapeutics from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $14.54 M149.83%
2025 $5.82 M
2024 N/A-100%
2023 $3.5 M147.52%
2022 $1.41 M-52.87%
2021 $3 M-70%
2020 $10 M
2019 N/A-100%
2018 $0.38 M-53.64%
2017 $0.83 M-5.85%
2016 $0.88 M-14.52%
2015 $1.04 M12.43%
2014 $0.92 M-54.7%
2013 $2.04 M-53.63%
2012 $4.4 M138.44%
2011 $1.84 M283.99%
2010 $0.48 M36.65%
2009 $0.35 M20.96%
2008 $0.29 M
2004 $0.54 M-57.61%
2003 $1.29 M12.9%
2002 $1.14 M372.02%
2001 $0.24 M
1999 $0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
$65.76 B 452,224.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
$0.61 B 4,101.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel